Regulacje i polityka gospodarcza · 26/11/1999

National Institutes of Health to Grant Exclusive License for Cancer Treatment Patent

The National Institutes of Health is considering granting an exclusive worldwide license to NeoPharm, Inc. for the use of a patent for a cancer treatment, specifically the SS(dsFv)-PE38 immunotoxin, for the therapeutic treatment of ovarian cancer and mesotheliomas.

Source: Federal Register — All DocumentsOpen original release →

Find a company or service

Business Communicator helps companies present their offer, publish updates and connect directly.

Create a company profile Explore businesses on Business Maps →

LATEST SIGNALS

Regulacje i polityka gospodarcza · 10/14/2026

Department of War Requests Comments on Proposed Manual for Courts-Martial Amendments

The Department of War (DoW) is seeking comments on proposed changes to the Manual for Courts-Martial (MCM) and has announced a public meeting to receive comments on the changes.

Read summary →